EUVIMEDEUVIMED entdecken
Crossref

Computational Investigation of Selected Antivirals and mAbs Targeting the RBD of Omicron to Get Insights into Structure and Binding Attributes

Sudheer Kumar Katari, Kesavi HimaBindhu Vuyyuru, Anil Kumar Singh

Molecular Modeling Connect · 09.05.2026 · 3 (1) · 1

DOI: 10.69709/molmodc.2026.190500 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Modeling Connect, online erschienen am 09.05.2026. Verfasst von Sudheer Kumar Katari und 2 weiteren Autor:innen. Die Arbeit nennt 79 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple mutations in SARS-CoV-2 (nCoV) have led to the emergence of VOCs. Mutations in the receptor- RBD can significantly influence viral interaction with cell surface receptors, alter pathogenicity, and facilitate immune evasion. Such VOCs pose a significant public health risk due to their ability to evade immune responses, as well as their altered pathogenicity and transmissibility. To address these challenges, we investigated the structure, function, and binding efficiency of the RBDs of VOCs using selected antiviral drugs and mAbs. The SSEs of the S protein of VOCs were found to comprise 26.79–29.43% α-helices (Hh), 21.64–22.37% extended strands (Ee), 3.54–5.12% β-turns (Tt), and 45.40–46.84% random coils (Cc). Docking simulations revealed that the nCoV-RBD-Lopinavir complex exhibited the lowest binding affinity (−8.8 ± 0.55 Kcal/mol), by forming hydrogen-bond interactions with ALA-27 and ALA-143 residues. Similarly, the Omicron RBD–Indinavir complex exhibited the lowest binding affinity (−7.4 ± 0.06 Kcal/mol), involving residues ARG355, ASP428, THR430, SER514, and GLU516 in hydrogen-bond interactions. Protein–protein docking of the Omicron RBD–ACE2 complex revealed a favorable docking score of −846.2, compared with the reference complex (−703.1). The findings presented herein highlight substantial structural and functional alterations in the Omicron RBD compared with the reference nCoV RBD. This variation showcases the diverse binding affinities of selected antiviral drugs and mAbs. These findings may pave the way for experimental validation and contribute to a deeper understanding of potential therapeutic options against SARS-CoV-2 and related diseases.

Zitieren

APA

Katari, S. K., Vuyyuru, K. H., & Singh, A. K. (2026). Computational Investigation of Selected Antivirals and mAbs Targeting the RBD of Omicron to Get Insights into Structure and Binding Attributes. Molecular Modeling Connect, 3(1), 1. https://doi.org/10.69709/molmodc.2026.190500

Vancouver

Katari SK, Vuyyuru KH, Singh AK. Computational Investigation of Selected Antivirals and mAbs Targeting the RBD of Omicron to Get Insights into Structure and Binding Attributes. Molecular Modeling Connect. 2026;3(1):1. doi:10.69709/molmodc.2026.190500

BibTeX
@article{Katari2026,
  author = {Katari, Sudheer Kumar and Vuyyuru, Kesavi HimaBindhu and Singh, Anil Kumar},
  title = {Computational Investigation of Selected Antivirals and mAbs Targeting the RBD of Omicron to Get Insights into Structure and Binding Attributes},
  journal = {Molecular Modeling Connect},
  year = {2026},
  volume = {3},
  number = {1},
  pages = {1},
  doi = {10.69709/molmodc.2026.190500}
}
Kostenlos starten →